The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey


Kılıçkap S., Ölmez Ö. F., Çiçin İ., Demirci U., Alan Ö., Çabuk D., ...More

European Society for Medical Onkology 2018 Congress, Munich, Germany, 19 - 23 October 2018

  • Publication Type: Conference Paper / Unpublished
  • Doi Number: 10.1093/annonc/mdy292.023
  • City: Munich
  • Country: Germany
  • Van Yüzüncü Yıl University Affiliated: Yes